Hu, Bing <br/><br/>
[Capecitabine combined with cisplatin as first-line therapy in Chinese patients with advanced gastric carcinoma-a phase II clinical study].  [electronic resource] 

 -  Zhonghua zhong liu za zhi [Chinese journal of oncology]  Dec 2008 
 - 940-3 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; English Abstract; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>0253-3766 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Capecitabine<br/>Cisplatin--administration & dosage<br/>Deoxycytidine--administration & dosage<br/>Female<br/>Fluorouracil--administration & dosage<br/>Follow-Up Studies<br/>Foot Dermatoses--chemically induced<br/>Hand Dermatoses--chemically induced<br/>Humans<br/>Leukopenia--chemically induced<br/>Liver Neoplasms--drug therapy<br/>Lung Neoplasms--drug therapy<br/>Lymphatic Metastasis<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Remission Induction<br/>Stomach Neoplasms--drug therapy<br/>Survival Rate<br/>Vomiting--chemically induced<br/>Young Adult